124 related articles for article (PubMed ID: 17403112)
21. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
22. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.
Talwar S; Squire IB; Davies JE; Barnett DB; Ng LL
Eur Heart J; 1999 Dec; 20(23):1736-44. PubMed ID: 10562482
[TBL] [Abstract][Full Text] [Related]
23. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
24. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure.
Baldasseroni S; Mannucci E; Orso F; Di Serio C; Pratesi A; Bartoli N; Marella GA; Colombi C; Foschini A; Valoti P; Mossello E; Fumagalli S; Marchionni N; Tarantini F
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):292-9. PubMed ID: 22032915
[TBL] [Abstract][Full Text] [Related]
26. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction.
Wu N; Ma F; Guo Y; Li X; Liu J; Qing P; Xu R; Zhu C; Jia Y; Liu G; Dong Q; Jiang L; Li J
Chin Med J (Engl); 2014; 127(4):627-32. PubMed ID: 24534213
[TBL] [Abstract][Full Text] [Related]
27. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
[TBL] [Abstract][Full Text] [Related]
28. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
[TBL] [Abstract][Full Text] [Related]
30. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
[TBL] [Abstract][Full Text] [Related]
32. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
33. NT-proBNP and BNP values in cardiac patients with different degree of left ventricular systolic dysfunction.
Kotaska K; Popelova J; Tiserova M; Telekes P; Vrzanova M; Bronsky J; Halacova M; Kukacka J; Prusa R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Jul; 150(1):125-30. PubMed ID: 16936915
[TBL] [Abstract][Full Text] [Related]
34. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
Jones E; Wei J; Nelson MD; Bakir M; Mehta PK; Shufelt C; Minissian M; Sharif B; Pepine CJ; Handberg E; Cook-Wiens G; Sopko G; Bairey Merz CN
PLoS One; 2020; 15(12):e0243213. PubMed ID: 33270715
[TBL] [Abstract][Full Text] [Related]
35. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease.
Sakai H; Tsutamoto T; Ishikawa C; Tanaka T; Fujii M; Yamamoto T; Takashima H; Horie M
Circ J; 2007 Apr; 71(4):499-505. PubMed ID: 17384449
[TBL] [Abstract][Full Text] [Related]
36. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
[TBL] [Abstract][Full Text] [Related]
37. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
[TBL] [Abstract][Full Text] [Related]
38. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.
März W; Tiran B; Seelhorst U; Wellnitz B; Bauersachs J; Winkelmann BR; Boehm BO;
Clin Chem; 2007 Jun; 53(6):1075-83. PubMed ID: 17446333
[TBL] [Abstract][Full Text] [Related]
39. Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.
Wu Z; Xu M; Sheng H; Lou Y; Su X; Chen Y; Lu L; Liu Y; Jin W
Int J Clin Exp Pathol; 2014; 7(10):7148-57. PubMed ID: 25400811
[TBL] [Abstract][Full Text] [Related]
40. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
